Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 181 to 195 of 476 results for learning disabilities

  1. Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA543)

    Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs.

    Technology appraisal guidance
    Published
    3 October 2018
    View recommendations

    Sections for TA543

  2. What is the most effective and cost-effective way of delivering the intervention (for example, type of physiotherapy or exercise, mode of delivery, number of sessions) to reduce arm and shoulder problems after breast cancer surgery or radiotherapy, and what is the acceptability of the intervention for different groups, such as: women, men, trans people and non-binary people people from minority ethnic family backgrounds people with learning disabilities or cognitive impairment, or physical disabilities, or both neurodiverse people?

    ethnic family backgrounds people with learning disabilities or cognitive impairment, or physical disabilities, or both...

    Research recommendation
    Published
    5 May 2023

  3. Published

    The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.

  4. Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA768)

    Evidence-based recommendations on upadacitinib (Rinvoq) for treating active psoriatic arthritis in adults.

    Technology appraisal guidance
    Published
    2 February 2022
    View recommendations

    Sections for TA768

  5. Multimorbidity: clinical assessment and management (NG56)

    This guideline covers optimising care for adults with multimorbidity (multiple long-term conditions) by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care. It aims to improve quality of life by promoting shared decisions based on what is important to each person in terms of treatments, health priorities, lifestyle and goals. The guideline sets out which people are most likely to benefit from an approach to care that takes account of multimorbidity, how they can be identified and what the care involves.

    NICE guideline
    Published
    21 September 2016
    View recommendations

    Sections for NG56

  6. Involving you in the development of our guidance

    Involving you in the development of NICE guidance.

  7. Involving you in the development of our guidance

    Involving you in the development of NICE guidance.

  8. Strategies to reduce arm and shoulder problems- What is the most effective and cost-effective way of delivering the intervention (for example, type of physiotherapy or exercise, mode of delivery, number of sessions) to reduce arm and shoulder problems after breast cancer surgery or radiotherapy, and what is the acceptability of the intervention for different groups, such as: women, men, trans people and non-binary people people from minority ethnic family backgrounds people with learning disabilities or cognitive impairment, or physical disabilities, or both neurodiverse people?

    ethnic family backgrounds people with learning disabilities or cognitive impairment, or physical disabilities, or both...

    Research recommendation
    Published
    7 August 2023

  9. Patient information: - What information on the management of flares do people with osteoarthritis, their family and carers need after diagnosis? - What information do people with osteoarthritis from different ethnic and socioeconomic groups, and those with learning disabilities, issues with health literacy and severe mental illness (and their family and carers), need?

    osteoarthritis from different ethnic and socioeconomic groups, and those with learning disabilities, issues with health literacy and...

    Research recommendation
    Published
    7 November 2022

  10. Delirium assessment tools:What is the diagnostic accuracy, and ease of implementation, of different delirium assessment tools: for people with pre-existing cognitive impairment, for example dementia, learning disability or severe depression for people who do not speak English as a first language in different settings, for example emergency departments, residential care homes or virtual consultations when delivered by different types of health and social care practitioners, for example healthcare assistants or allied health professionals such as paramedics?

    people with pre-existing cognitive impairment, for example dementia, learning disability or severe depression for people...

    Research recommendation
    Published
    3 February 2023

  11. Bimekizumab for treating moderate to severe plaque psoriasis (TA723)

    Evidence-based recommendations on bimekizumab (Bimzelx) for treating moderate to severe plaque psoriasis in adults.

    Technology appraisal guidance
    Published
    1 September 2021
    View recommendations

    Sections for TA723

  12. Older people with social care needs and multiple long-term conditions (NG22)

    This guideline covers planning and delivering social care and support for older people who have multiple long-term conditions. It promotes an integrated and person-centred approach to delivering effective health and social care services.

    NICE guideline
    Published
    4 November 2015
    View recommendations

    Sections for NG22

  13. Physical health of people in prisons (QS156)

    This quality standard covers assessing, diagnosing and managing physical health problems of adults aged 18 years and older in prisons or young offender institutes. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    7 September 2017
    View quality statements

    Sections for QS156

  14. Developmental follow-up of children and young people born preterm (QS169)

    This quality standard covers the developmental follow-up of babies, children and young people under 18 years who were born preterm (before 37+0 weeks of pregnancy). It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    18 May 2018
    View quality statements

    Sections for QS169

  15. Abortion care (QS199)

    This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    26 January 2021
    View quality statements

    Sections for QS199